Stockreport

Olezarsen Priority Review and Expanding Rare Disease Franchise Could Be A Game Changer For Ionis (IONS) [Yahoo! Finance]

Ionis Pharmaceuticals, Inc.  (IONS) 
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ionispharma.com
PDF revenue guidance of US$800 million to US$825 million, and reported 2025 results showing revenue rising to US$944 million with a full-year net loss of US$381 million. T [Read more]